PD 0332991 HCl 英文名称: PD 0332991 HCl | ||||||||||||||||||||||||||||||||||||||||||||||||||||
型号:null 产品货号: ICC1102-0005MG | ||||||||||||||||||||||||||||||||||||||||||||||||||||
价格:请致电:010-57128832,18610462672 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
品牌: gene operation | ||||||||||||||||||||||||||||||||||||||||||||||||||||
ICC1102-PD 0332991 HCl PD 0332991 HCl,>99% 【英文同义名】:Palbociclib hydrochloride, PD 0332991 HCl, Palbociclib HCl, Tube006 订购信息:(原装进口,常备现货)
产品描述 PD 0332991 HCl 是PD 0332991的盐酸盐形式。PD 0332991是一种具有选择性CDK4和CDK6抑制剂,IC50分别为11nM 和 16nM。PD 0332991对包括CDK1/ 2/5,EGFR,FGFR,PDGFR和胰岛素受体等36种蛋白激酶没有活性。体外实验中PD 0332991能抑制视网膜母细胞瘤阳性肿瘤细胞的生长,包括停留细胞周期到G1期,降低Rb蛋白Ser780/ Ser795的***酸化。PD 0332991能消减Colo-205人结肠癌移植小鼠移植瘤 [1]。PD 0332991也能在体内外抑制5T33MM细胞Rb蛋白Cdk4/6特异性***酸化及细胞周期G(1)期 [2]。PD 0332991治疗原发性乳腺癌能够使Ki67降低4倍以上 [3]。PD 0332991处理能阻断大肠癌细胞RB蛋***酸化并抑制细胞生长 [4]。PD 0332991已进入临床三期实验用于治疗乳腺肿瘤。 靶点
化学特性
储存液配制
结构式使用浓度(仅作参考)PD 0332991 HCl的具体使用浓度请参考相关文献,并根据自身实验条件(如实验目的,细胞种类,培养特性等)进行摸索和优化。 参考文献[1] Fry DW, et al. Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. Mol Cancer Ther. 3(11):1427-38(2004). [2] Menu E, et al. A novel therapeutic combination using PD 0332991 and bortezomib: study in the 5T33MM myeloma model. Cancer Res. 68(14):5519-23(2008). [3] Witkiewicz AK, et al. CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models. Genes Cancer. 5(7-8):261-72(2014). [4] Li C, Qi L, et al. PD-0332991 induces G1 arrest of colorectal carcinoma cells through inhibition of the cyclin-dependent kinase-6 and retinoblastoma protein axis. Oncol Lett. 7(5):1673-1678(2014). |